Fig. 2From: Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel diseaseIndividual courses of clinical activity scores using the short paediatric Crohn’s disease activity index (shPCDAI) in the CD cohort (a) and the paediatric ulcerative colitis activity index (PUCAI) in the UC cohort (b)Back to article page